Teva's Generic Zocor Exclusivity Upheld
Generic drug maker Sandoz Inc.'s efforts to prevent Teva Pharmaceuticals from marketing its generic version of cholesterol drug Zocor have been thwarted, after a judge upheld Teva's right to a 180-day...To view the full article, register now.
Already a subscriber? Click here to view full article